Information model of Chinese materia medica processing

Information model of Chinese materia medica processing

Regular price
£166.00
Sale price
£166.00
Regular price
£83.00
Sold out
Unit price
per 

What is ISO/TS 21831 about? 

ISO/TS 21831 discusses the specification model for Chinese materia medica processing.  

ISO/TS 21831 specifies an information model within the field of Chinese materia medica processing. 

ISO/TS 21831 defines a set of domain constraints of sanctioned characteristics, each composed of a relationship and an applicable model. 

ISO/TS 21831 model aims at representing the concepts applicable to Chinese materia medica processing in the making of decoction pieces. 

Note: ISO/TS 21831 is not applicable to Japanese traditional Kampo medicine. 

Who is ISO/TS 21831 for? 

ISO/TS 21831 on CMM processing is applicable to: 

  • Manufacturers, suppliers, processors of raw materials used in Chinese medicine 
  • Regulatory bodies 
  • The medical and pharmaceutical industry 

Why should you use ISO/TS 21831? 

Chinese materia medica (CMM) is a medicinal part of medical plants, animals, and minerals after preliminary processing, which are used as raw materials in Chinese medicines. 

While a large number of relevant trials have been conducted to assess the function of decoction pieces of CMM, the descriptions of processing in reports tend to be insufficient for the interpretation of heterogeneity among trials, often causing difficulties for data synthesis in meta-analyses. This is mainly due to two reasons: firstly, because of the lack of use of an appropriate information model of the processing of CMM, and secondly because semantic associations between concepts of CMM processing have yet to be explicitly identified. 

The formal concept representation system in the field of CMM processing includes characterizing categories and semantic links, which is covered by ISO/TS 21831. 

Overall, compliance with the information model can be essential in establishing standardized safety and health guidelines, thereby enhancing credibility and trust in CMM products. This can also result in fostering commerce of CMM-based Chinese medicines.